Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma

BACKGROUND AND PURPOSE: Pre-treatment ADC characteristics have been shown to predict response to bevacizumab in recurrent glioblastoma multiforme. However, no studies have examined whether ADC characteristics are specific to this particular treatment. The purpose of the current study was to determin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AJNR Am J Neuroradiol
Main Authors: Ellingson, B.M., Sahebjam, S., Kim, H.J., Pope, W.B., Harris, R.J., Woodworth, D.C., Lai, A., Nghiemphu, P.L., Mason, W.P., Cloughesy, T.F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Neuroradiology 2014
Assuntos:
Brain
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7965805/
https://ncbi.nlm.nih.gov/pubmed/24136647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A3748
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados